4
Orphan Designations
2
FDA Approvals
7
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| CD4+/CD56+ hematodermic neoplasm | ELZONRIS | Orphan Designation | - |
| acute myeloid leukemia | 5,6-dibromo-4-nitro-2-(piperidin-4-yl)-1-(propan-2-yl)-1H-1,3-benzodiazole hydrochloridehuman interleukin-3 genetically conjugated to diphtheria toxin protein | Orphan Designation | - |
| blast phase chronic myelogenous leukemia, BCR-ABL1 positive | ELZONRIS | Orphan Designation | - |
| glioma | human leukocyte antigen-A2 restricted peptides | Orphan Designation | - |
| myelodysplastic syndrome with excess blasts-1 | ELZONRIS | Orphan Designation | - |
| myelodysplastic syndrome with excess blasts-2 | ELZONRIS | Orphan Designation | - |
| plastic bronchitis | ELZONRIS | Orphan Designation | - |